Viral entry route determines how human plasmacytoid dendritic cells produce type i interferons

Science Signaling

Volumn 8, Issue 366, 2015, Pages ra25-

  Bruni, Daniela ^a   Chazal, Maxime ^a   Sinigaglia, Laura ^a   Chauveau, Lise ^a   Schwartz, Olivier ^a   Desprès, Philippe ^a,b   Jouvenet, Nolwenn ^a  

^a INSTITUT PASTEUR   (France)

^b Processus Infectieux en Milieu Insulaire Tropicale I2T Team   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; MESSENGER RNA; PATTERN RECOGNITION RECEPTOR; RETINOIC ACID INDUCIBLE GENE 1 LIKE RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 7; UNCLASSIFIED DRUG; VIRUS RNA; YELLOW FEVER VACCINE; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN; TLR7 PROTEIN, HUMAN;

ADULT; ARTICLE; CELL CONTACT; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; RNA REPLICATION; VIRUS ENTRY; VIRUS REPLICATION; ANIMAL; BIOSYNTHESIS; CHLOROCEBUS AETHIOPS; DENDRITIC CELL; FEMALE; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PLASMA CELL; VERO CELL LINE; VIROLOGY; YELLOW FEVER VIRUS;

RNA VIRUSES;

ADULT; ANIMALS; CERCOPITHECUS AETHIOPS; DEAD-BOX RNA HELICASES; DENDRITIC CELLS; FEMALE; HUMANS; INTERFERON TYPE I; MALE; PLASMA CELLS; RNA, VIRAL; TOLL-LIKE RECEPTOR 7; VERO CELLS; VIRUS INTERNALIZATION; VIRUS REPLICATION; YELLOW FEVER VIRUS;

EID: 84924105256     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.aaa1552     Document Type: Article

References (61)

1. A. Iwasaki, A virological view of innate immune recognition. Annu. Rev. Microbiol. 66, 177-196 (2012).
2. J. W. Schoggins, S. J.Wilson, M. Panis, M. Y. Murphy, C. T. Jones, P. Bieniasz, C. M. Rice, A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481-485 (2011).
3. M. Gilliet, W. Cao, Y. J. Liu, Plasmacytoid dendritic cells: Sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8, 594-606 (2008).
4. B. Reizis, A. Bunin, H. S. Ghosh, K. L. Lewis, V. Sisirak, Plasmacytoid dendritic cells: Recent progress and open questions. Annu. Rev. Immunol. 29, 163-183 (2011).
5. K. Matsui, Y. Kumagai, H. Kato, S. Sato, T. Kawagoe, S. Uematsu, O. Takeuchi, S. Akira, Cutting edge: Role of TANK-binding kinase 1 and inducible IkB kinase in IFN responses against viruses in innate immune cells. J. Immunol. 177, 5785-5789 (2006).
6. H. Kato, S. Sato, M. Yoneyama, M. Yamamoto, S. Uematsu, K. Matsui, T. Tsujimura, K. Takeda, T. Fujita, O. Takeuchi, S. Akira, Cell type-specific involvement of RIG-I in antiviral response. Immunity 23, 19-28 (2005).
7. Q. Sun, L. Sun, H. H. Liu, X. Chen, R. B. Seth, J. Forman, Z. J. Chen, The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24, 633-642 (2006).
8. S. S. Diebold, T. Kaisho, H. Hemmi, S. Akira, C. Reis e Sousa, Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303, 1529-1531 (2004).
9. J. M. Lund, L. Alexopoulou, A. Sato, M. Karow, N. C. Adams, N. W. Gale, A. Iwasaki, R. A. Flavell, Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. U.S.A. 101, 5598-5603 (2004).
10. M. Macal, G. M. Lewis, S. Kunz, R. Flavell, J. A. Harker, E. I. Zúñiga, Plasmacytoid dendritic cells are productively infected and activated through TLR-7 early after arenavirus infection. Cell Host Microbe 11, 617-630 (2012).
11. C. Asselin-Paturel, A. Boonstra, M. Dalod, I. Durand, N. Yessaad, C. Dezutter-Dambuyant, A. Vicari, A.O'Garra, C. Biron, F. Brière,G. Trinchieri, Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2, 1144-1150 (2001).
12. H. K. Lee, J. M. Lund, B. Ramanathan, N. Mizushima, A. Iwasaki, Autophagydependent viral recognition by plasmacytoid dendritic cells. Science 315, 1398-1401 (2007).
13. J. P. Wang, P. Liu, E. Latz, D. T. Golenbock, R. W. Finberg, D. H. Libraty, Flavivirus activation of plasmacytoid dendritic cells delineates key elements of TLR7 signaling beyond endosomal recognition. J. Immunol. 177, 7114-7121 (2006).
14. A. S. Beignon, K. McKenna, M. Skoberne, O. Manches, I. DaSilva, D. G. Kavanagh, M. Larsson, R. J. Gorelick, J. D. Lifson, N. Bhardwaj, Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J. Clin. Invest. 115, 3265-3275 (2005).
15. M. Dreux, U. Garaigorta, B. Boyd, E. Décembre, J. Chung, C. Whitten-Bauer, S.Wieland, F. V. Chisari, Short range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 12, 558-570 (2012).
16. S. F. Wieland, K. Takahashi, B. Boyd, C. Whitten-Bauer, N. Ngo, J. C. de la Torre, F. V. Chisari, Human pDCs Sense LCMV Infected Cells in vitro. J. Virol. 88, 752-757 (2013).
17. K. Takahashi, S. Asabe, S. Wieland, U. Garaigorta, P. Gastaminza, M. Isogawa, F. V. Chisari, Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc. Natl. Acad. Sci. U.S.A. 107, 7431-7436 (2010).
18. A. Lepelley, S. Louis, M. Sourisseau, H. K. Law, J. Pothlichet, C. Schilte, L. Chaperot, J. Plumas, R. E. Randall, M. Si-Tahar, F. Mammano, M. L. Albert, O. Schwartz, Innate sensing of HIV-infected cells. PLOS Pathog. 7, e1001284 (2011).
19. R. Rua, A. Lepelley, A. Gessain, O. Schwartz, Innate sensing of foamy viruses by human hematopoietic cells. J. Virol. 86, 909-918 (2012).
20. S. Python, M. Gerber, R. Suter, N. Ruggli, A. Summerfield, Efficient sensing of infected cells in absence of virus particles by plasmacytoid dendritic cells is blocked by the viral ribonuclease Erns. PLOS Pathog. 9, e1003412 (2013).
21. S. Zhang, K. Kodys, G. J. Babcock, G. Szabo, CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha. Hepatology 58, 940-949 (2013).
22. V. Hornung, J. Schlender,M.Guenthner-Biller,S.Rothenfusser, S.Endres,K.K.Conzelmann, G. Hartmann, Replication-dependent potent IFN-a induction in human plasmacytoid dendritic cells by a single-stranded RNA virus. J. Immunol. 173, 5935-5943 (2004).
23. N. Marr, T. I.Wang, S. H. Kam, Y. S. Hu, A. A. Sharma, A. Lam, J. Markowski, A. Solimano, P. M. Lavoie, S. E. Turvey, Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children. J. Immunol. 192, 948-957 (2014).
24. C. L. Ku, H. von Bernuth, C. Picard, S. Y. Zhang, H. H. Chang, K. Yang, M. Chrabieh, A. C. Issekutz, C. K. Cunningham, J. Gallin, S. M. Holland, C. Roifman, S. Ehl, J. Smart, M. Tang, F. J. Barrat, O. Levy, D. McDonald, N. K. Day-Good, R. Miller, H. Takada, T. Hara, S. Al-Hajjar, A. Al-Ghonaium, D. Speert, D. Sanlaville, X. Li, F. Geissmann, E. Vivier, L. Maródi, B. Z. Garty, H. Chapel, C. Rodriguez-Gallego, X. Bossuyt, L. Abel, A. Puel, J. L. Casanova, Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J. Exp. Med. 204, 2407-2422 (2007).
25. A. E. Stone, S. Giugliano, G. Schnell, L. Cheng, K. F. Leahy, L.Golden-Mason, M. Gale Jr., H. R. Rosen, Hepatitis C virus pathogen associated molecular pattern (PAMP) triggers production of lambda-interferons by human plasmacytoid dendritic cells. PLOS Pathog. 9, e1003316 (2013).
26. M. D. Fernandez-Garcia, M. Mazzon, M. Jacobs, A. Amara, Pathogenesis of flavivirus infections: Using and abusing the host cell. Cell Host Microbe 5, 318-328 (2009).
27. T. P. Monath, A. D. Barrett, Pathogenesis and pathophysiology of yellow fever. Adv. Virus Res. 60, 343-395 (2003).
28. K. C. Meier, C. L. Gardner, M. V. Khoretonenko, W. B. Klimstra, K. D. Ryman, A mouse model for studying viscerotropic disease caused by yellow fever virus infection. PLOS Pathog. 5, e1000614 (2009).
29. T. D. Querec, R. S. Akondy, E. K. Lee, W. Cao, H. I. Nakaya, D. Teuwen, A. Pirani, K. Gernert, J. Deng, B. Marzolf, K. Kennedy, H. Wu, S. Bennouna, H. Oluoch, J. Miller, R. Z. Vencio, M. Mulligan, A. Aderem, R. Ahmed, B. Pulendran, Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10, 116-125 (2009).
30. E. F. Wheelock, W. A. Sibley, Circulating virus, interferon and antibody after vaccination with the 17-D strain of yellow-fever virus. N. Engl. J. Med. 273, 194-198 (1965).
31. D. Gaucher, R. Therrien, N. Kettaf, B. R. Angermann, G. Boucher, A. Filali-Mouhim, J. M. Moser, R. S. Mehta, D. R. Drake 3rd, E. Castro, R. Akondy, A. Rinfret, B. Yassine-Diab, E. A. Said, Y. Chouikh, M. J. Cameron, R. Clum, D. Kelvin, R. Somogyi, L. D. Greller, R. S. Balderas, P. Wilkinson, G. Pantaleo, J. Tartaglia, E. K. Haddad, R. P. Sékaly, Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205, 3119-3131 (2008).
32. J. L. Muñoz-Jordán, B. L. Fredericksen, How flaviviruses activate and suppress the interferon response. Viruses 2, 676-691 (2010).
33. A. Mancino, M. Habbeddine, E. Johnson, L. Luron, M. Bebien, S. Memet, C. Fong, M. Bajenoff, X. Wu, M. Karin, J. Caamano, H. Chi, M. Seed, T. Lawrence, I kappa B kinase alpha (IKKa) activity is required for functional maturation of dendritic cells and acquired immunity to infection. EMBO J. 32, 816-828 (2013).
34. K. Clark, O. Takeuchi, S. Akira, P. Cohen, The TRAF-associated protein TANK facilitates cross-talk within the IkB kinase family during Toll-like receptor signaling. Proc. Natl. Acad. Sci. U.S.A. 108, 17093-17098 (2011).
35. D. Bruni, J. Sebastia, S. Dunne, M. Schroder, M. P. Butler, A novel IRAK1-IKKe signaling axis limits the activation of TAK1-IKKb downstream of TLR3. J. Immunol. 190, 2844-2856 (2013).
36. F. J. Barrat, R. L. Coffman, Development of TLR inhibitors for the treatment of autoimmune diseases. Immunol. Rev. 223, 271-283 (2008).
37. E. Y. Chiang, X. Yu, J. L. Grogan, Immune complex-mediated cell activation from systemic lupus erythematosus and rheumatoid arthritis patients elaborate different requirements for IRAK1/4 kinase activity across human cell types. J. Immunol. 186, 1279-1288 (2011).
38. T. Querec, S. Bennouna, S. Alkan, Y. Laouar, K. Gorden, R. Flavell, S. Akira, R. Ahmed, B. Pulendran, Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 203, 413-424 (2006).
39. L. Chaperot, A. Blum, O. Manches, G. Lui, J. Angel, J. P. Molens, J. Plumas, Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. J. Immunol. 176, 248-255 (2006).
40. S. Chang, K. Kodys, G. Szabo, Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells. Hepatology 51, 35-42 (2010).
41. H. L. Lu, F. Liao, Melanoma differentiation-associated gene 5 senses hepatitis B virus and activates innate immune signaling to suppress virus replication. J. Immunol. 191, 3264-3276 (2013).
42. Y. M. Loo, J. Fornek, N. Crochet, G. Bajwa, O. Perwitasari, L. Martinez-Sobrido, S. Akira, M. A. Gill, A. García-Sastre, M. G. Katze, M. Gale Jr., Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82, 335-345 (2008).
43. J. Rehwinkel, C. P. Tan, D. Goubau, O. Schulz, A. Pichlmair, K. Bier, N. Robb, F. Vreede, W. Barclay, E. Fodor, C. Reis e Sousa, RIG-I detects viral genomic RNA during negativestrand RNA virus infection. Cell 140, 397-408 (2010).
44. L. Strahle, D. Garcin, D. Kolakofsky, Sendai virus defective-interfering genomes and the activation of interferon-beta. Virology 351, 101-111 (2006).
45. M. O. Diaz, S. Ziemin, M. M. Le Beau, P. Pitha, S. D. Smith, R. R. Chilcote, J. D. Rowley, Homozygous deletion of the a- and b1-interferon genes in human leukemia and derived cell lines. Proc. Natl. Acad. Sci. U.S.A. 85, 5259-5263 (1988).
46. A. Breiman, N. Grandvaux, R. Lin, C. Ottone, S. Akira, M. Yoneyama, T. Fujita, J. Hiscott, E. F. Meurs, Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKe. J. Virol. 79, 3969-3978 (2005).
47. K. Eisenacher, A. Krug, Regulation of RLR-mediated innate immune signaling-It is all about keeping the balance. Eur. J. Cell Biol. 91, 36-47 (2012).
48. H. An, J. Hou, J. Zhou, W. Zhao, H. Xu, Y. Zheng, Y. Yu, S. Liu, X. Cao, Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat. Immunol. 9, 542-550 (2008).
49. I. Abu-Dayyeh, M. T. Shio, S. Sato, S. Akira, B. Cousineau, M. Olivier, Leishmaniainduced IRAK-1 inactivation is mediated by SHP-1 interacting with an evolutionarily conserved KTIM motif. PLOS Negl. Trop. Dis. 2, e305 (2008).
50. R. L. Tiwari, V. Singh, A. Singh, M. K. Barthwal, IL-1R-associated kinase-1 mediates protein kinase Cd-induced IL-1b production in monocytes. J. Immunol. 187, 2632-2645 (2011).
51. S. Y. Zhang, E. Jouanguy, V. Sancho-Shimizu, H. von Bernuth, K. Yang, L. Abel, C. Picard, A. Puel, J. L. Casanova, Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses. Immunol. Rev. 220, 225-236 (2007).
52. A. M. Nour, Y. Li, J. Wolenski, Y. Modis, Viral membrane fusion and nucleocapsid delivery into the cytoplasm are distinct events in some flaviviruses. PLOS Pathog. 9, e1003585 (2013).
53. J. N. Mandl, R. Akondy, B. Lawson, N. Kozyr, S. I. Staprans, R. Ahmed, M. B. Feinberg, Distinctive TLR7 signaling, type I IFN production, and attenuated innate and adaptive immune responses to yellow fever virus in a primate reservoir host. J. Immunol. 186, 6406-6416 (2011).
54. A. Szabo, Z. Magyarics, K. Pazmandi, L. Gopcsa, E. Rajnavolgyi, A. Bacsi, TLR ligands upregulate RIG-I expression in human plasmacytoid dendritic cells in a type I IFNindependent manner. Immunol. Cell Biol. 92, 671-678 (2014).
55. V. Pascual, D. Chaussabel, J. Banchereau, A genomic approach to human autoimmune diseases. Annu. Rev. Immunol. 28, 535-571 (2010).
56. T. J. Chambers, D. W. McCourt, C. M. Rice, Production of yellow fever virus proteins in infected cells: Identification of discrete polyprotein species and analysis of cleavage kinetics using region-specific polyclonal antisera. Virology 177, 159-174 (1990).
57. A. Lefeuvre, H. Contamin, T. Decelle, C. Fournier, J. Lang, V. Deubel, P. Marianneau, Host-cell interaction of attenuated and wild-type strains of yellow fever virus can be differentiated at early stages of hepatocyte infection. Microbes Infect. 8, 1530-1538 (2006).
58. C. T. Jones, C. G. Patkar, R. J. Kuhn, Construction and applications of yellow fever virus replicons. Virology 331, 247-259 (2005).
59. J. B. Brault, M. Kudelko, P. O. Vidalain, F. Tangy, P. Desprès, N. Pardigon, The interaction of flavivirus M protein with light chain Tctex-1 of human dynein plays a role in late stages of virus replication. Virology 417, 369-378 (2011).
60. K. J. Livak, T. D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCt Method. Methods 25, 402-408 (2001).
61. D. Rudnicka, J. Feldmann, F. Porrot, S. Wietgrefe, S. Guadagnini, M. C. Prévost, J. Estaquier, A. T. Haase, N. Sol-Foulon, O. Schwartz, Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses. J. Virol. 83, 6234-6246 (2009).